Taipei Medical University Clinical Research Database (TMUCRD) – A Collaborative Hospital EHR Database Aligned with International Common Data Standards
Nguyen, P.A.; Hsu, M.H.; Chang, T.H.; Yang, H.C.E.; Huang, C.W.; Liao, C.T.; Lu, C.Y.; Hsu, Jason C.* (2024/05), BMJ Health & Care Informatics [SCI]
Cost-Effectiveness Analysis of Granulocyte Colony-Stimulating Factors for the Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Patients with Breast Cancer in Taiwan
Tseng, T.H.; Chiang, S.C.; Hsu, J.C.; Ko, Y.* (2024/05), PLOS One [SCI]
Unveiling the Future of COVID-19 Patient Care: Groundbreaking Prediction Models for Severe Outcomes or Mortality in Hospitalized Cases
Hien, N.T.K.; Tsai1, F.J.; Chang, Y.H.; Burton, W.; Phuc, P.T. et al. (2024/01), Frontiers in Medicine, (in press) [SCI] (IF: 5.058)
Anti-osteoporosis Drugs Reduce Mortality in Cancer Patients: A National Cohort Study of Elderly with Vertebral Fractures
Huang, C.F.; Kuo, T.T.; Hsu, J.C.*; Kosik, R.O.; Chan, W.P.* (2023/10), Annals, Academy of Medicine, Singapore (in press) [SCI] (IF: 5.2)
Near infrared imaging system for preventing blood vision obstruction in endoscopy
Wu, M.H.#; Hsu, J.C.#; Kim, J.S.; Huang, T.J.; Huang, Y.H.; Yiu, H.P.; Lee, C.Y.; Tani, J.*; Chang, C.C.* (2023/11) Optics Express, (in press) [SCI]
Ranitidine use and incident cancer in a multinational cohort
You, S.C.; Seo, S.I.; Falconer, T. et al. (2023/09) “Ranitidine use and incident cancer in a multinational cohort”, JAMA Network Open, 2023 Sep 5;6(9):e2333495. [SCI] (IF: 13.353)
A novel prediction model of the risk of pancreatic cancer among diabetes patients using multiple clinical data and machine learning
Chen, S.M.; Phuc, P.T.; Nguyen, P.A.; Lin, S.J.; Lin, W.C.; Lu, C.Y.; Hsu, M.H.; Cheng, C.T.; Hsu, J.C.* (2023/08) , Cancer Medicine, (in press) [SCI] (IF: 4.711)
Prescription patterns of granulocyte colony–stimulating factors in patients with breast cancer: a real-world study
Hsu, S.W.; Chiang, S.C.; Hsu, J.C. (2023/07) PLOS One, (in press) [SCI]
Machine Learning and Deep Learning Approaches for Predicting 5-year Survival of Patients with Breast Cancer
Quynh, N.T.N.; Wang, C.J.; Nguyen, P.A.; Phuc, P.T.; Lin, R.K.; Hung, C.S.; Kuo, N.H.; Cheng, Y.W.; Cheng, C.T.; Hsu, M.H.*; Hsu, J.C.* (2023/07) Cancer Science (in press) [SCI] (IF: 6.518)
Age and gender differences in misperceptions of body shape in a Taiwanese population
Weng, H.C.; Chang, S.M.; Hsu, J.C.; Yang, Y.N.; Lin, C.Y. (2023/06) Journal of Eating Disorders, (in press) [SCI] (IF: 4.916)
Emotion recognition in doctor-patient interactions from real-world clinical video database: Initial development of artificial empathy
Huang, C. W., Wu, B. C. Y., Nguyen, P. A., Wang, H. H., Kao, C. C., Lee, P. C., Rahmanti, A. R., Hsu, J. C., Yang, H. C. & Li, Y. C. J. (2023/05) Computer Methods and Programs in Biomedicine. 233, 10
Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: A
Lee, H.L.; Cheng, P.L.; Wu, P.H.; Kao, W.Y.; Lai, Y.T.; Hsu, J.C.; Chiou, J.F.; Wu, M.H. (2023/03) Experimental Hematology & Oncology [SCI] (IF: 8.593)
Advantages of DES over BMS in preventing the risk of myocardial infarction, ischemic stroke and mortality in various populations
Wu, P.N.; Chen, J.H.; Yang, C.P.; Hsu, J.C.* (2023/1), Journal of Clinical Medicine, 12(1), 24; https://doi.org/10.3390/jcm12010024 [SCI]
Comparison Between Lumbar Endoscopic Unilateral Laminotomy for Bilateral Decompression and Other Decompression Approaches for Lumbar Spinal Stenosis: A Systematic Review
Chiang, P.L.; Chen, Y.Y.; Chen, K.T.; Hsu, J.C.; Wu, C.; Lee, C.Y.; Huang, T.J.; Huang, Y.H.; Chen, C.M.; Wu, M.H.* (2022/12) , World Neurosurgery, 168, 369-380. [SCI]
Association Between Proton Pump Inhibitor Use and the Risk of Female
Nguyen, N.T.H.; Huang, C.W.; Wang, C.H.; Lin, M.C.; Hsu, J.C.; Hsu, M.H.; Iqbal, U.; Nguyen, P.-A. Yang, H.C.* (2022/12), Cancers, (in press) [SCI] (IF: 6.575)
Evidence on the Utility and Limitations to Using AI for Personalized Drug Safety Prediction
Hsu, J.C.; Lu, C.Y. (2022/12) In: Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Springer, Cham. https://doi.org/10.1007/978-3-030-50247-8_99-1
Development and Validation of Novel Deep-Learning Models using Multiple Data Types for Lung Cancer Survival
Hsu, J.C.; Nguyen, P.-A.; Phuc, P.T.; Lo, T.C.; Hsu, M.H.; Hsieh, M.S.; Le, N.Q.K.; Cheng, C.T.; Chang, T.H.*; Chen, C.Y.* (2022/11) , Cancers, 14, 5562. https://doi.org/10.3390/cancers14225562 [SCI]
Comparison of long-term outcomes of spinal fusion surgeries supplemented with “topping-off” implants in lumbar degenerative diseases: a systematic review and network meta-analysis
Chiou, K.; Chiu, Y.C.; Lee, C.Y.; Huang, T.J.; Lai, Y.C.; Yang, C.J.; Hsu, J.C.*; Wu, M.H.* (2022/10), North American Spine Society Journal, 12:100177. doi: 10.1016/j.xnsj.2022.100177. eCollection 202
Effectiveness and safety of immunosuppressants and biological therapy for chronic spontaneous urticaria: a network meta-analysis
Lin, W.K.; Lin, S.J.; Lee, W.R.; Lin, C.C.; Lin, W.C.; Chang, H.C.; Cheng, C.T.; Hsu, J.C.* (2022/09) , Biomedicines, 10(9):2152. doi: 10.3390/biomedicines10092152. [SCI]
Reduced all-cause mortality with bisphosphonates among post-fracture osteoporosis patients: a nationwide study and systematic review
Hsu, Y.H.; Li, C.C.; Liang, F.W.; Peng, Z.Y.; Chang, Y.F.; Hsu, J.C.; Ou, H.T.; Wu, C.H.* (2022/09), Clinical Pharmacology & Therapeutics, 112(3):711-719. doi: 10.1002/cpt.2645. Epub 2022 Jun 4. [SCI]
Determinants of COVID-19 infection by artificial intelligence technology: a study of 28 countries
Peng, H.Y.; Lin, Y.K.; Nguyen, P.A.; Hsu, J.C.*; Chou, C.L.; Chang, C.C.; Lin, C.C.; Lam, C.; Chen, C.I.; Wang, K.H.; Lu, C.Y. (2022/08), PLOS One, 17(8):e0272546. [SCI]
The impact of various anti-osteoporosis drugs on all-cause mortality after hip fractures: A nationwide population study
Tai, T.W.; Hwang, J.S.; Li, C.C.; Hsu, J.C.; Chang, C.W.; Wu, C.H.* (2022/08) , Journal of Bone and Mineral Research, 37(8):1520-1526. doi: 10.1002/jbmr.4627. Epub 2022 Jun 25. [SCI] (IF: 6.390)
Evidence on the Utility and Limitations of Artificial Intelligence for Predicting Personalized Disease Prognosis and Treatment Decisions
Hsu, J.C.; Lu, C.Y. (2022/08)In: Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Springer, Cham. https://doi.org/10.1007/978-3-030-50247-8_98-1
Association of Air Pollution and Weather Factors with Traffic Injury Severity: A Study in Taiwan
Ta-Chien Chan; Chih-Wei Pai; Chia-Chieh Wu; Jason C. Hsu; Ray-Jade Chen; Wen-Ta Chiu; Carlos Lam* (2022/06), International Journal of Environmental Research and Public Health [SCI]
Reduced all-cause mortality with bisphosphonates among post-fracture osteoporosis patients: a nationwide study and systematic review
Hsu, Y.H.; Li, C.C.; Liang, F.W.; Peng, Z.Y.; Chang, Y.F.; Hsu, J.C.; Ou, H.T.; Wu, C.H.* (2022/05), Clinical Pharmacology & Therapeutics, accepted, in press [SCI]
Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort
Lu, Y.*; Zandt, M.V.; Liu, Y.; Li, J.; Wang, X.; Chen, Y.; Chen, Z.; Cho, J.; Dorajoo, S.R.; Feng, M.; Hsu, M.H.; Hsu, J.C. et al. (2022/03), JAMA Network Open, 5(3):e223877 [SCI]
The association between osteoporosis medications and lowered all-cause mortality after hip or vertebral fracture in older and oldest-old adults: A nationwide population-based study
Li, C.C.#; Hsu, J.C.#; Liang, F.W.; Chang, Y.F.; Chiu, C.J.*; Wu, C.H.* (2022/03), Aging, in press [SCI]
Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan
Poon, S.Y.K.; Hsu, J.C.; Ko, Y.; Chiang, S.C.* (2021/11) , Healthcare, 9, 1600. [SCI]
Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-analysis
Hung, S.A.; Liao, C.L.; Lin, W.P.; Hsu, J.C.; Guo, Y.H.; Lin, Y.C.* (2021/11), Children, 8, 1089. https://doi.org/10.3390/children8121089. [SCI]
雙磷酸鹽類藥物使用對骨鬆骨折病人死亡率的影響－健保資料庫分析
許育煊；李佳純；梁富文；張尹凡；徐之昇*；吳至行* (2021/09) ，台灣家庭醫學雜誌，31(3): 199-213.
Association of Social Media with Cancer Screening Awareness and Behavior for People without a Cancer Diagnosis: Matched Cohort Study
Qin, L.; Zhang, X.; Wu, A.; Miser, J.S.; Liu, Y.L.; Hsu, J.C.; Shia, B.C.; Ye, L. (2021/08), Journal of Medical Internet Research, 23(8):e26395. doi: 10.2196/26395. [SCI]
Public Awareness as a Line of Defense against COVID-19 in Taiwan
Tseng, P.; Tsai, F.J.; Hsu, J.C.; Chang, Y.C.; Wang, K.H.; Wu, M.K.; Chen, M.; Su, C.H.; Shia, B.C.; Miser, J.S. (2021/07), Asia Pacific Journal of Public Health, 10105395211030126
The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients with Stage III/IV: A multicenter study
Hsu, J.C.*; Nguyen, P.A.; Chen, Y.T.; Yang, S.C.; Lin, C.C.; Yang, Y.H.; Lin, Y.C.; Hsia, T.C.; Hsieh, H.C.; Wu, J.S.; Chang, C.P.; Feng, Y.H.; Lin, P.C. et al. (2021/07), , Frontiers in Oncology, (in
A cost-utility analysis of avelumab for metastatic Merkel cell carcinoma in Taiwan
Chang, W.C.; Lin, A.Y.; Hsu, J.C.; Wu, C.E.; Goh, C.; Chou, P.; Kuo, K.; Chang, A.; Palencia, R. (2021/05), Cancer Reports, e1399. doi: 10.1002/cnr2.1399. Online ahead of print.
A Real-World Observational Study of Drug Utilization and Clinical Outcomes of Direct-acting Antivirals and Interferon Therapy for Hepatitis C Treatment in Taiwan
Chen, J.H.; Wu, P.N.; Huang, S.C.; Hsu, P.J.; Hsu, J.C.* (2021/02)Current Medical Research and Opinion, 37(2): 245-252. doi: 10.1080/03007995.2020.1857716. [SCI]
Health Inequality: A Longitudinal Study on Geographic Variations in Lung Cancer Incidence and Mortality in Taiwan
Hsu, J.C.*; Tseng, Y.C.; Chang, S.M.; Lee, Y.C.; Lin, P.C.; Chu, H.J. (2020/6), BMC Public Health, 20(1): 951. [SCI]
Lung Cancer Survival and Mortality in Taiwan following the Initial Launch of Targeted Therapies: An Interrupted Time Series Study
Hsu, J.C.*; Wei, C.F.; Yang, S.C.; Lin, P.C.; Lee, Y.C.; Lu, C.Y. (2020/05), BMJ Open. May 10;10(5):e033427. doi: 10.1136/bmjopen-2019-033427. [SCI]
Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan
Yang, S.C.; Lai, W.W.; Hsu, J.C.; Su, W.C.; Wang, J.D.* (2020/04) , PLOS One, 15(4):e0231413. doi: 10.1371/journal.pone.0231413. eCollection 2020. [SCI]
Comprehensive Value Assessment of Drugs using a Multi-Criteria Decision Analysis: An Example of Targeted Therapies for Metastatic Colorectal Cancer Treatment
Hsu, J.C.*; Lin, J.Y.; Lin, P.C.; Lee, Y.C. (2019/12) , PLOS One, 14(12):e0225938. doi: 10.1371/journal.pone.0225938. eCollection 2019. [SCI]
Budget Impact Analysis of Osteoporosis Medications for Primary Prevention of Fractures in Taiwan
Wu, K.L.; Wu, C.H.; Chang, Y.F.; Lin, Y.T.; Hsu, J.C.* (2019/11) , Journal of Bone and Mineral Metabolism. doi: 10.1007/s00774-019-01061-5. [SCI]
Effects of Removing Reimbursement Restrictions on Targeted Therapy Accessibility for Non-small Cell Lung Cancer Treatment in Taiwan: an Interrupted Time Series Study
Hsu, J.C.*; Wei, C.F.; Yang, S.C. (2019/03), BMJ Open, 9:e022293. doi:10.1136/bmjopen-2018-022293[SCI]
Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-glucose Cotransporter-2 Inhibitors on Oral Antidiabetic Drug Utilization
Chen, H.Y.; Chiu, P.Y.; Chang, C.J.; Tsao, L.L.; Huang, Y.L.; Hsu, J.C.* (2018/12) , Clinical Drug Investigation. doi: 10.1007/s40261-018-0689-2. [SCI]
Use of Assisted Reproductive Technologies before and after the Artificial Reproduction Act in Taiwan
Hsu, J.C.*; Su, Y.C.; Tang, B.Y.; Lu, C.Y. (2018/11), PLOS One. 13(11):e0206208. doi: 10.1371/journal.pone.0206208. eCollection 2018. [SCI]
Disease and Economic Burden for Rare Diseases in Taiwan: A Longitudinal Study Using Taiwan’s National Health Insurance Research Database
Hsu, J.C.*; Wu, H.C.; Feng, W.C.; Chou, C.H.; Lai, E.C.C.; Lu C.Y. (2018/09), PLOS One. 13(9):e0204206. doi: 10.1371/journal.pone.0204206. eCollection [SCI]
Effectiveness and Safety of Immune Checkpoint Inhibitors: A Retrospective Study in Taiwan
Hsu, J.C.*; Lin, J.Y.; Hsu, M.Y.; Lin, P.C. (2018/08), PLOS One. 13(8):e0202725. doi: 10.1371/journal.pone.0202725. eCollection [SCI]
Geographic Variations and Time Trends in Cancer Treatments in Taiwan
Hsu, J.C.*; Chang, S.M.; Lu, C.Y. (2017/08), BMC Public Health, 18(1):89. doi: 10.1186/s12889-017-4615-y. [SCI]
10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan’s National Health Insurance Research Database
Hsieh, H.C.; Hsu, J.C.*; Lu, C.Y. (2017/05), BMJ Open, 7(5): e014150. [SCI]
Trend and Geographic Analysis of Prevalence of Dengue in Taiwan (2010-2015)
Hsu, J.C.*; Hsieh, C.L.; Lu, C.Y. (2017/01), International Journal of Infectious Diseases, 54(1): 43-49. [SCI]
Longitudinal Trends in Use and Costs of Targeted Therapies for Common Cancers in Taiwan: A Retrospective Observational Study
Hsu, J.C.*; Lu, C.Y. (2016/06) , BMJ Open, 6(6):e011322. [SCI]
Longitudinal Trends in Targeted Therapies Use for Treatment of Malignant Neoplasms of The Eye: A Population-based Study in Taiwan
Hsu, J.C.*; Gonzalez-Gonzalez, LA.; Lu, V.H.; Lu, C.Y. (2016/05), BMJ Open, 6(5):e010706. [SCI]
Effects of Safety Warnings and Risk Management Plan for Thiazolidinediones in Taiwan
Hsu, J.C.; Cheng, C.L.; Ross-Degnan, D.; Wagner, A.K.; Zhang, F.; Kao Yang, Y.H.*; Liu, L.L.; Tai, H.Y.; Chen, K.H.; Yang, P.W.; Lu, C.Y. (2015/10) , Pharmacoepidemiology and Drug Safety, 24(10): 1026
How did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?
Hsu, J.C.*; Ross-Degnan, D.; Wagner, A.K.; Zhang, F.; Lu, C.Y. (2015/07) , Clinical Therapeutics, 37(7): 1420-1432 e1. [SCI]
Net Clinical Benefit of Oral Anticoagulants: A Multiple Criteria Decision Analysis
Hsu, J.C.*; Hsieh, C.Y.; Yang Kao, Y.H.; Lu, C.Y. (2015/04), PLOS One, 10(4): e0124806. [SCI]
Risk-Benefit Assessment of Oral Phosphodiesterase Type 5 Inhibitors for treatment of Erectile Dysfunction: A Multiple Criteria Decision Analysis
Hsu, J.C.*; Tang, D.H.; Lu, C.Y. (2015/04), International Journal of Clinical Practice, 69(4): 436-443. [SCI]
Utilization of Oral Antidiabetic Medications in Taiwan following Strategies to Promote Access to Medicines for Chronic Diseases in Community Pharmacies
Hsu, J.C.*; Ross-Degnan, D.; Wagner, A.K.; Cheng, C.L.; Kao Yang, Y.H.; Zhang, F. Lu, C.Y. (2015/04) , Journal of Pharmaceutical Policy and Practice, 8(1): 15-23.
The Evolution of Taiwan’s National Health Insurance Drug Reimbursement Scheme
Hsu, J.C.*; Lu, C.Y. (2015/02), DARU Journal of Pharmaceutical Sciences, 23: 15-21. [SCI]
Impacts of Drug Reimbursement Reductions on Utilization and Expenditures of Oral Antidiabetic Medications in Taiwan: An Interrupted Time Series Study
Hsu, J.C.*; Lu, C.Y.; Wagner, A.; Chan, K.W.; Lai, M.S.; Ross-Degnan, D. (2014/06), Health Policy, 116(2): 196-205. [SSCI]
Utilization Patterns of Anti-hyperuricemic Agents Following Safety Announcement on Allopurinol and Benzbromarone by Taiwan Food and Drug Administration
Cheng, C.L.; Chao, P.H.; Hsu, J.C.; Weng, M.M.Y.; On, A.W.F.; Yang Kao, Y.H.* (2014/03) , Pharmacoepidemiology and Drug Safety, 23(3): 309-313. [SCI]
A Dynamic Game Theoretic Approach on Chinese Pharmaceutical Firms’ International Strategic Alliance
Hsu, C.S.* and Wu, C.S. (2013/12), Innovation: Management, Policy & Practice, 15(3): 350-363. [SSCI]
Linking International High-tech New Ventures’ Firm Life Cycle to Internationalization, Organizational Learning, and Alliance Networks
Wu, C.S. and Hsu, C.S.* (2013/02), Journal of Enterprising Culture, 21(2):175-197. [ABI]